Efficacy and safety of monlunabant in adults with obesity and metabolic syndrome: a double-blind, randomised, placebo-controlled, phase 2a trial
Who should consider standard dosing instead Microdosing isnt the right starting point for everyone: BMI 35+ with significant weight to lose: Standard dosing protocols are backed by robust clinical trial data
Remember, your weight loss journey is unique, and there's no one-size-fits-all approach
To keep muscle strong while losing weight, Prado says it is essential to focus on two main things: nutrition and exercise
She attended Gannon University in Erie, PA for both her bachelors degree and Master of Physician Assistant Studies
Importantly, Retatrutide's unique triple receptor agonismtargeting GLP-1, GIP, and glucagon receptorsappears well-tolerated, with adverse events largely consistent with known effects from the broader GLP-1 class, primarily mild gastrointestinal symptoms such as nausea, decreased appetite, and occasional diarrhea, typically resolving within a few weeks of initiation
